Supreme Court rejects Apotex's challenge to Plavix's patent, without comment. Plavix, an...

|By:, SA News Editor

Supreme Court rejects Apotex's challenge to Plavix's patent, without comment. Plavix, an anti-clotting drug with yearly sales of more than $6B, was developed by Sanofi-Aventis (SNY -0.05%) and is co-marketed by Bristol-Myers (BMY +0.7%).